New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 9, 2014
07:31 EDTBCLIBrainStorm Cell appoints Fiorino CEO
BrainStorm Cell Therapeutics announced that it has appointed Tony Fiorino as its new CEO. Previously, Fiorino was founder, president and CEO of EnzymeRx, where he led the acquisition of a late-stage pre-clinical biologic and the development of the compound through Phase 1/2 clinical trials and its subsequent sale to 3SBio.
News For BCLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
08:58 EDTBCLIBrainStorm CEO underappreciated by investors, Feuerstein says
BrainStorm CEO Tony Fiorino is "one of the most honest and diligent investors in the health care sector," TheStreet's Adam Feuerstein writes after interviewing the executive. Feuerstein believes Fiorino is being underappreciated by investors. Shares of the microcap company seeking to development a treatment for amyotrophic lateral sclerosis are up 20% to $4.15 in pre-open trading. Reference Link
October 7, 2014
09:14 EDTBCLIOn The Fly: Pre-market Movers
Subscribe for More Information
07:11 EDTBCLIBrainStorm Cell's NurOwn designated as Fast Track product by FDA
Subscribe for More Information
October 6, 2014
09:03 EDTBCLIBrainStorm Cell reports last patient visit in Phase 2a ALS study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use